| mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.002 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.003 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.007 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.01 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.01 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.01 |
| mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |